"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 14 | 14 |
| 1996 | 0 | 16 | 16 |
| 1997 | 0 | 17 | 17 |
| 1998 | 0 | 31 | 31 |
| 1999 | 0 | 21 | 21 |
| 2000 | 0 | 19 | 19 |
| 2001 | 1 | 24 | 25 |
| 2002 | 0 | 32 | 32 |
| 2003 | 0 | 34 | 34 |
| 2004 | 0 | 37 | 37 |
| 2005 | 0 | 32 | 32 |
| 2006 | 1 | 41 | 42 |
| 2007 | 0 | 33 | 33 |
| 2008 | 0 | 30 | 30 |
| 2009 | 0 | 31 | 31 |
| 2010 | 0 | 35 | 35 |
| 2011 | 0 | 39 | 39 |
| 2012 | 0 | 33 | 33 |
| 2013 | 0 | 29 | 29 |
| 2014 | 1 | 29 | 30 |
| 2015 | 0 | 48 | 48 |
| 2016 | 0 | 33 | 33 |
| 2017 | 0 | 37 | 37 |
| 2018 | 0 | 49 | 49 |
| 2019 | 0 | 35 | 35 |
| 2020 | 0 | 44 | 44 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 19 | 19 |
| 2023 | 0 | 14 | 14 |
| 2024 | 0 | 22 | 22 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. Clin Cancer Res. 2024 Dec 02; 30(23):5304-5313.
-
Outcomes Associated With Novel Oral Anticoagulants and Warfarin in Patients With Cardiac Thrombus Following ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2025 Feb 01; 236:72-78.
-
The impact of electronic cigarette aerosol exposure on spatial memory formation: Modulation by orally administered vitamin E. Neurotoxicology. 2024 Dec; 105:263-271.
-
Direct Oral Anticoagulants for Rheumatic?Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC Clin Electrophysiol. 2024 Dec; 10(12):2701-2710.
-
Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
-
Development and acceptability of a decision-aid for food allergy oral immunotherapy in children. Allergy. 2025 Jan; 80(1):205-214.
-
Oral decitabine-cedazuridine in acute myeloid leukaemia. Br J Haematol. 2024 Nov; 205(5):1674-1676.
-
Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence. Int J Clin Pharm. 2024 Dec; 46(6):1525-1535.
-
Addressing common questions on food oral immunotherapy: a practical guide for paediatricians. Arch Dis Child. 2024 08 16; 109(9):697-701.
-
Use of Direct Oral Anticoagulants in Patients With Peripheral Artery Disease: A Meta-Analysis. Am J Cardiol. 2024 Sep 01; 226:34-35.